Incidence and Outcome of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) in a Population-Based Cohort of 3165 Patients in Sweden

被引：0
|
作者：
Harrysson, Sara [1 ,2 ]
Eloranta, Sandra [1 ]
Ekberg, Sara [1 ]
Enblad, Gunilla [3 ]
Jerkeman, Mats [4 ]
Hasselblom, Sverker [5 ]
Wahlin, Bjorn E. [2 ,6 ]
Andersson, Per-Ola [7 ,8 ]
Smedby, Karin E. [1 ,2 ]
机构：
[1] Karolinska Inst, Div Clin Epidemiol, Dept Med Solna, Stockholm, Sweden
[2] Karolinska Univ Hosp, Dept Hematol, Solna, Sweden
[3] Akad Univ Hosp, Dept Oncol, Uppsala, Sweden
[4] Lund Univ, Inst Clin Sci, Dept Oncol & Pathol, Lund, Sweden
[5] Reg Halland, Dept Res Dev & Educ, Halmstad, Sweden
[6] Karolinska Inst, Div Hematol, Dept Med Huddinge, Stockholm, Sweden
[7] South Alvsborg Hosp, Dept Hematol, Boras, Sweden
[8] Gothenburg Univ, Sahlgrenska Acad, Gothenburg, Sweden
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-110672
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2975
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Phase II study of single-agent copanlisib in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL).
    Lenz, Georg
    Hawkes, Eliza
    Verhoef, Gregor
    Haioun, Corinne
    Thye, Lim Soon
    Heo, Dae Seog
    Ardeshna, Kirit
    Chong, Geoffrey
    Christensen, Jacob Haaber
    Shi, Vivian
    Lippert, Susanne
    Niemeyer, Florian
    Piraino, Paolo
    Pena, Carol Elaine
    Buvaylo, Viktoriya
    Childs, Barrett H.
    Gorbatchevsky, Igor
    Salles, Gilles A.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [32] Increased Incidence of Autoimmune and Infectious Diseases Among a Large Group of Diffuse Large B-Cell Lymphoma (DLBCL) Survivors: A Population-Based Study
    Shree, Tanaya
    Li, Qian
    Glaser, Sally L.
    Maecker, Holden T.
    Haile, Robert W.
    Levy, Ronald
    Keegan, Theresa H. M.
    BLOOD, 2017, 130
  • [33] The Fate of Patients with Refractory Diffuse Large B Cell Lymphoma (DLBCL)
    Otahal, Pavel
    Janikova, Andrea
    Belada, David
    Prochazka, Vit
    Mocikova, Heidi
    Pirnos, Jan
    Duras, Juraj
    Kopeckova, Katerina
    Campr, Vit
    Pytlik, Robert
    Blahovcova, Petra
    Trneny, Marek
    BLOOD, 2018, 132
  • [34] Treatment intensity and survival in patients with relapsed or refractory diffuse large B-cell lymphoma in Denmark: a real-life population-based study
    Arboe, Bente
    Olsen, Maja Halgren
    Gorlov, Jette Sonderskov
    Duun-Henriksen, Anne Katrine
    Dalton, Susanne Oksbjerg
    Johansen, Christoffer
    Brown, Peter de Nully
    CLINICAL EPIDEMIOLOGY, 2019, 11 : 207 - 216
  • [35] Polatuzumab vedotin in relapsed/refractory diffuse large B-cell lymphoma
    Dietliker, N.
    Kiesel, H.
    Mueller, R.
    Mueller, A. M.
    Manz, M. G.
    Zenz, T.
    Rosler, W.
    SWISS MEDICAL WEEKLY, 2020, : 21S - 21S
  • [36] Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Schuster, Stephen J.
    Bishop, Michael R.
    Tam, Constantine S.
    Waller, Edmund K.
    Borchmann, Peter
    McGuirk, Joseph P.
    Jaeger, Ulrich
    Jaglowski, Samantha
    Andreadis, Charalambos
    Westin, Jason R.
    Fleury, Isabelle
    Bachanova, Veronika
    Foley, S. Ronan
    Ho, P. Joy p
    Mielke, Stephan
    Magenau, John M.
    Holte, Harald
    Pantano, Serafino
    Pacaud, Lida B.
    Awasthi, Rakesh
    Chu, Jufen
    Anak, Ozlem
    Salles, Gilles
    Maziarz, Richard T.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (01): : 45 - 56
  • [37] Clinical Pharmacology of CTL019 in Patients with Relapsed/Refractory (r/r) Diffuse Large B-Cell Lymphoma (DLBCL)
    Awasthi, Rakesh
    Tam, Constantine S.
    Jaeger, Ulrich
    Jaglowski, Samantha
    Foley, Stephen Ronan
    Van Besien, Koen
    Wagner-Johnston, Nina D.
    Kersten, Marie Jose
    Schuster, Stephen J.
    Salles, Gilles Andre
    Maziarz, Richard Thomas
    Anak, Oezlem
    Pacaud, Lida Bubuteishvili
    Gazi, Lucien
    Waldron, Edward
    Hamilton, Jason
    Pruteanu, Iulian
    Tai, Feng
    Mueller, Karen Thudium
    Waller, Edmund K.
    BLOOD, 2017, 130
  • [38] Magrolimab in Combination with Rituximab plus Chemotherapy in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)
    Maakaron, Joseph
    Asch, Adam S.
    Popplewell, Leslie L.
    Collins, Graham P.
    Flinn, Ian W.
    Ghosh, Nilanjan
    Keane, Colin
    Ku, Matthew
    Mehta, Amitkumar
    Roschewski, Mark
    O'Hear, Carol
    Ren, Xuehan
    Villa, Bertha
    Lal, Indu
    Smith, Sonali M.
    Advani, Ranjana H.
    BLOOD, 2022, 140 : 3728 - 3730
  • [39] Novel agents in relapsed/refractory diffuse large B-cell lymphoma
    Varma, Gaurav
    Goldstein, Jordan
    Advani, Ranjana H.
    HEMATOLOGICAL ONCOLOGY, 2023, 41 : 92 - 106
  • [40] Novel Therapies for Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Harris, Leonard Jeff
    Patel, Kruti
    Martin, Michael
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (22) : 1 - 12
12345